**Core Concept**
Trigeminal neuralgia is a chronic pain condition affecting the trigeminal nerve, characterized by sudden, severe, and shock-like or stabbing pain in the face. The first-line management involves pharmacological interventions to alleviate symptoms.

**Why the Correct Answer is Right**
The first-line treatment for trigeminal neuralgia typically involves carbamazepine, a tricyclic anticonvulsant that helps stabilize abnormal electrical activity in the trigeminal nerve. Carbamazepine works by blocking voltage-gated sodium channels, thereby reducing the frequency and severity of pain episodes. This mechanism is particularly effective in managing trigeminal neuralgia, as it targets the underlying pathophysiology of the condition.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as lamotrigine is not the first-line treatment for trigeminal neuralgia, although it may be used as an adjunct therapy in some cases.
**Option B:** This option is incorrect as baclofen is primarily used to treat muscle spasticity, not trigeminal neuralgia.
**Option C:** This option is incorrect as pregabalin is used to treat various conditions, including epilepsy and neuropathic pain, but it is not the first-line treatment for trigeminal neuralgia.

**Clinical Pearl / High-Yield Fact**
It is essential to note that carbamazepine should be initiated at a low dose and gradually increased to minimize the risk of side effects. Additionally, patients with a history of hypersensitivity reactions to other anticonvulsants should be closely monitored when starting carbamazepine.

**Correct Answer: A. Carbamazepine**